Related Experiment Video
Updated: Jul 13, 2026
06:03
Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis
Published on: February 6, 2020
BCoR-L1 variation and breast cancer
Felicity Lose1, Jeremy Arnold, David B Young
1Cancer and Cell Biology Division, Queensland Institute of Medical Research, 300 Herston Road, Brisbane, Queensland, Australia, 4006.
Breast Cancer Research : BCR
|August 19, 2007
Summary
This study investigated BCL6 corepressor-like 1 (BCoR-L1) in familial breast cancer risk. Results indicate BCoR-L1 expression is unlikely to be a major factor in predisposition to breast cancer.
Area of Science:
- Genetics and Genomics
- Cancer Biology
- Molecular Oncology
Background:
- BRCA1 is crucial in cellular processes and breast cancer. Many breast cancer susceptibility genes interact with BRCA1.
- BCL6 corepressor-like 1 (BCoR-L1), a BRCA1-interacting protein, is involved in DNA repair and transcription regulation.
- BCoR-L1 gene expression is dysregulated in breast cancer and it is located on the X chromosome, subject to X inactivation.
Purpose of the Study:
- To investigate the role of BCoR-L1 as a high-risk breast cancer predisposition gene.
- To determine if BCoR-L1 dysregulation contributes to familial breast and prostate cancer.
- To analyze BCoR-L1 mutation and expression in BRCA1/2 mutation-negative families.
Main Methods:
- Mutation analysis was performed on 38 BRCA1/2 mutation-negative families with specific cancer histories.
- Quantitative real-time PCR (qRT-PCR) assessed BCoR-L1 expression in lymphoblastoid cell lines and cancer cell lines.
- DIDO1 was identified as a superior reference gene for expression analysis in lymphoblastoid cell lines.
Main Results:
- Minimal variation was found in the coding region of BCoR-L1.
- BCoR-L1 expression exhibited high variability across cancer-free subjects, high-risk breast cancer patients, and cancer cell lines.
- DIDO1 demonstrated superior performance over GAPDH and UBC as an expression control in lymphoblastoid cell lines.
Conclusions:
- BCoR-L1 expression does not appear to play a significant role in predisposition to familial breast cancer.
- Further research may be needed to fully elucidate the role of BCoR-L1 in cancer biology.
- The identification of DIDO1 offers an improved method for gene expression studies in lymphoblastoid cell lines.
Related Concept Videos
01:21Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...